Stryker (SYK) Income from Continuing Operations (2009 - 2026)
Stryker (SYK) posted quarterly Income from Continuing Operations of 1276000000.0 for Q2 2026, up 44.34% year-over-year from 884000000.0 in Q2 2025, and up 71.28% on a QoQ basis from 745000000.0 in Q1 2026.
Stryker (SYK) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Stryker has reported Income from Continuing Operations for 18 years, with the latest figure at 1276000000.0 in Q2 2026.
- Income from Continuing Operations for Q2 2026 came in at 1276000000.0, up 44.34% year-over-year; the trailing twelve-month figure through Jun 2026 was 3729000000.0 (up 27.79% YoY), and the FY2025 annual result was 3246000000.0, up 8.45% from the prior year.
- Income from Continuing Operations rose to 1276000000.0 in Q2 2026, from 745000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1276000000.0 in Q2 2026 and troughed at 323000000.0 in Q1 2022.
- A 5-year average of 765722222.22 and a median of 766500000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The widest annual swing landed in 2023, when Income from Continuing Operations jumped 103.02%; it then plunged 52.23% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 563000000.0 in 2022, then jumped by 103.02% to 1143000000.0 in 2023, then plunged by 52.23% to 546000000.0 in 2024, then soared by 55.49% to 849000000.0 in 2025, then surged by 50.29% to 1276000000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 1276000000.0 in Q2 2026, 745000000.0 in Q1 2026, and 849000000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Bn |
| Mar 31, 2026 | 745.00 Mn |
| Dec 31, 2025 | 849.00 Mn |
| Sep 30, 2025 | 859.00 Mn |
| Jun 30, 2025 | 884.00 Mn |
| Mar 31, 2025 | 654.00 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Sep 30, 2024 | 834.00 Mn |
| Jun 30, 2024 | 825.00 Mn |
| Mar 31, 2024 | 788.00 Mn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 692.00 Mn |
| Jun 30, 2023 | 738.00 Mn |
| Mar 31, 2023 | 592.00 Mn |
| Dec 31, 2022 | 563.00 Mn |
| Sep 30, 2022 | 816.00 Mn |
| Jun 30, 2022 | 656.00 Mn |
| Mar 31, 2022 | 323.00 Mn |
| Dec 31, 2021 | 662.00 Mn |
| Sep 30, 2021 | 438.00 Mn |